JAK3 and non-small cell lung carcinoma: We cotransfected PART1‐sh with pcDNA‐JAK1 or JAK3 into A549 and H1650 cells to determine whether the regulation of PART1 on NSCLC progression was through JAK‐STAT signaling pathway.